Logo American Journal of Case Reports

Call: 1.631.629.4328
Mon-Fri 10 am - 2 pm EST

Contact Us

Logo American Journal of Case Reports Logo American Journal of Case Reports Logo American Journal of Case Reports

01 April 2004

Treatment with HMG-CoA reductase inhibitors and fibrates results in a long-term reduction of markers of disease severity in PBC

Makoto Nakamuta, Kazuhiro Kotoh, Munechika Enjoji, Hajime Nawata

Case Rep Clin Pract Rev 2004; 5(null):537-541 :: ID: 428992

Abstract

Background: 3-hydroxy-3-methylglutaryl coenzyme A-reductase inhibitor as well as fibrate, lipid-lowering drugs, recently has been reported to reduce disease markers of primary biliary cirrhosis (PBC). Case Report: We report the long-term observation of a case of PBC treated sequentially with several lipidlowering drugs and the effects of these drugs on the liver function tests. A 39-year-old female was diagnosed as PBC because of liver dysfunction accompanying high levels of immunoglobulin M (IgM), positive antimitochondrial antibody (AMA), and histological findings as stage II of PBC. She was also diagnosed as familial hypercholesteremia (IIa) because of her family history. She was treated with ursodeoxycholic acid (UDCA), which led to a transient improvement in liver function tests. Consequently, she was sequentially given several lipid-lowering drugs, probucol, bezafibrate, pravastatin and atorvastatin in addition to UDCA because of high levels of cholesterol. Bezafibrate, pravastatin, and atrovastatin, but not probucol, reduce disease markers of PBC. Particularly, long-term treatment with atorvastatin for more than 2.5 years led to continuously improving most significantly, not only the colesterol levels, but also liver function tests including IgM and AMA, compared to the other lipid-lowering drugs used throughout the clinical course. There were no side effects throughout the treatment. Conclusions: Our case indicates that statins, as well as fibrates, could ameliorate PBC in the long-term without side effects, suggesting that statins may be a first-line treatment for PBC particularly in patients with hypercholesteremia.

Keywords: PBC, HMG-CoA reductase inhibitors, Statin, fibrates, Probucol, Multiple drug-resistant gene (MDR), Phospholipid, Ursodeoxycholic acid (UDCA)

Add Comment 0 Comments

111

In Press

Case report  Portugal

Bartter Syndrome Presenting as Arginine-Vasopressin Resistance: A Report of 2 Cases

Am J Case Rep In Press; DOI: 10.12659/AJCR.942872  

Case report  China (mainland)

Extended Left Hemihapatectomy with Right Hepatic Artery Reconstruction for Primary Hepatic Neuroendocrine N...

Am J Case Rep In Press; DOI: 10.12659/AJCR.943721  

Case report  Austria

Smoking-Associated Endotracheal Hair Growth: A Case Report on Tracheal Complications

Am J Case Rep In Press; DOI: 10.12659/AJCR.943909  

Case report  Japan

Virtual Reality-Guided Simulation for Percutaneous Coronary Intervention in a Patient with Anatomical Anoma...

Am J Case Rep In Press; DOI: 10.12659/AJCR.944485  

Most Viewed Current Articles

07 Mar 2024 : Case report  USA 38,124

Neurocysticercosis Presenting as Migraine in the United States

DOI :10.12659/AJCR.943133

Am J Case Rep 2024; 25:e943133

0:00

10 Jan 2022 : Case report  Germany 31,073

A Report on the First 7 Sequential Patients Treated Within the C-Reactive Protein Apheresis in COVID (CACOV...

DOI :10.12659/AJCR.935263

Am J Case Rep 2022; 23:e935263

19 Jul 2022 : Case report  Saudi Arabia 17,693

Atlantoaxial Subluxation Secondary to SARS-CoV-2 Infection: A Rare Orthopedic Complication from COVID-19

DOI :10.12659/AJCR.936128

Am J Case Rep 2022; 23:e936128

23 Feb 2022 : Case report  USA 17,607

Penile Necrosis Associated with Local Intravenous Injection of Cocaine

DOI :10.12659/AJCR.935250

Am J Case Rep 2022; 23:e935250

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

American Journal of Case Reports eISSN: 1941-5923
American Journal of Case Reports eISSN: 1941-5923